13F filer · CIK 1603466 ↗
Point72
You are looking at Q3 2020. See the latest, Q2 2026 →
Reported value
$19.53B
+27% on the quarter before
Positions
895
406 new · 289 sold out
Top 10
16.0%
of the value
Est. gain
+$730.3M
on stocks held all quarter
Est. return
+8.4%
on those stocks since Q2 2020
Positions as of Sep 30, 2020, from Point72's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 26% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2020. Striped tiles are options.
Largest buys
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Palantir~$284.1MNew · 0.0% → 1.5%+29,904,230 shares
- Alphabet~$234.0MAdded · 0.4% → 1.5%+159,683 shares
- Eli Lilly~$194.9MNew · 0.0% → 1.0%+1,316,541 shares
- Meta~$194.3MAdded · 0.1% → 1.1%+741,827 shares
- SPDR S&P 500 ETF TrPUT~$179.2MAdded · 2.5% → 3.0%+535,000 underlying
- Csx Corp~$140.2MNew · 0.0% → 0.7%+1,805,275 shares
- Invesco Qqq TrPUT~$138.9MNew · 0.0% → 0.7%+500,000 underlying
- Microsoft~$134.4MAdded · 0.5% → 1.1%+638,941 shares
- AMD~$108.6MNew · 0.0% → 0.6%+1,324,712 shares
- Monster Beverage Corp New~$97.0MNew · 0.0% → 0.5%+1,209,357 shares
Largest sells
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Immunomedics Inc~$345.0MCut · 1.0% → 0.1%−4,057,664 shares
- Merck & Co. Inc~$170.3MCut · 1.8% → 0.7%−2,053,133 shares
- Canadian Natl Ry Co~$139.4MCut · 0.8% → 0.0%−1,308,742 shares
- CrowdStrike~$123.3MCut · 0.8% → 0.2%−897,743 shares
- Nxp Semiconductors N V~$122.2MCut · 1.4% → 0.6%−979,095 shares
- Fidelity Natl Information Sv~$121.6MCut · 0.8% → 0.1%−826,290 shares
- Salesforce~$105.1MSold out · 0.7% → 0.0%−561,201 shares
- Sailpoint Technlgies Hldgs I~$102.6MCut · 0.6% → 0.1%−2,593,311 shares
- Oracle~$87.2MCut · 0.8% → 0.3%−1,461,170 shares
- Sony Corp~$86.4MCut · 0.5% → 0.0%−1,127,128 shares
Holdings
As of Sep 30, 2020. Changes are in shares against Jun 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrPUTTR UNIT · shares +44% | 3.0% | $589.4M | — | ||||||||
| AmazonCOM · shares +19% · price +14.1% | 2.5% | $495.1M | +$51.6M | ||||||||
| AlibabaSPONSORED ADS · shares −12% · price +36.3% | 2.1% | $413.4M | +$110.1M | ||||||||
| AlphabetCAP STK CL A · shares +362% · price +3.4% | 1.5% | $298.7M | +$2.1M | ||||||||
| PalantirCL A · shares New | 1.5% | $284.1M | — | ||||||||
| MetaCL A · shares +758% · price +15.3% | 1.1% | $219.9M | +$3.4M | ||||||||
| PayPalCOM · shares +50% · price +13.1% | 1.1% | $212.6M | +$16.5M | ||||||||
| MicrosoftCOM · shares +186% · price +3.4% | 1.1% | $206.6M | +$2.3M | ||||||||
| Fiserv IncCOM · shares −26% · price +5.6% | 1.1% | $205.2M | +$10.8M | ||||||||
| Eli LillyCOM · shares New | 1.00% | $194.9M | — | ||||||||
| Dell Technologies IncCL C · shares +2.5% · price +23.2% | 0.87% | $170.3M | +$31.3M | ||||||||
| T-Mobile Us IncCOM · shares +84% · price +9.8% | 0.81% | $159.1M | +$7.7M | ||||||||
| Alexion Pharmaceuticals IncCOM · shares +13% · price +2.0% | 0.80% | $156.4M | +$2.7M | ||||||||
| Renaissancere Hldgs LtdCOM · shares −0.6% · price −0.8% | 0.75% | $146.1M | −$1.1M | ||||||||
| Haemonetics CorpCOM · shares +104% · price −2.6% | 0.74% | $145.4M | −$1.9M | ||||||||
| Arch Cap Group LtdORD · shares +20% · price +2.1% | 0.73% | $142.5M | +$2.4M | ||||||||
| Csx CorpCOM · shares New | 0.72% | $140.2M | — | ||||||||
| Invesco Qqq TrPUTUNIT SER 1 · shares New | 0.71% | $138.9M | — | ||||||||
| Jd.Com IncSPON ADR CL A · shares −24% · price +29.0% | 0.67% | $130.4M | +$29.3M | ||||||||
| Raytheon Technologies CorpCOM · shares +91% · price −6.6% | 0.67% | $130.2M | −$4.8M | ||||||||
| Merck & Co. IncCOM · shares −57% · price +7.3% | 0.66% | $128.0M | +$8.7M | ||||||||
| QorvoCOM · shares +137% · price +16.7% | 0.65% | $126.6M | +$7.7M | ||||||||
| Pinterest IncCL A · shares +17% · price +87.2% | 0.62% | $120.2M | +$47.9M | ||||||||
| Danaher CorporationCOM · shares +3.4% · price +21.8% | 0.60% | $116.9M | +$20.2M | ||||||||
| Las Vegas Sands CorpCOM · shares +13% · price +2.5% | 0.60% | $116.7M | +$2.5M | ||||||||
| Total · 895 positions | 100% | $19.53B | +$730.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2020 to Q3 2020: 476 stocks held throughout, up $730.3M (+8.4%).
- Alibaba+$110.1M+36%
- Amazon+$51.6M+14%
- Pinterest Inc+$47.9M+87%
- Dell Technologies Inc+$31.3M+23%
- L Brands Inc+$30.9M+112%
- Schlumberger Ltd−$8.1M−15%
- Targa Res Corp−$10.5M−30%
- Tricida Inc−$12.0M−67%
- Gw Pharmaceuticals Plc−$13.1M−21%
- Royal Dutch Shell Plc−$21.9M−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $90.68B+16% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $78.05B−13% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $89.42B+50% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $59.76B+17% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $50.94B+16% | SEC ↗ |
| Q1 2025 | Jul 21, 2025 (amended) | $43.81B−3% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $45.39B+15% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $39.34B+3% | SEC ↗ |
| Q2 2024 | Sep 16, 2024 (amended) | $38.21B−7% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $41.26B−0% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $41.35B+21% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $34.27B+2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $33.63B+4% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $32.29B+10% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $29.42B+18% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $25.04B+6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $23.70B−6% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $25.19B+1% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $25.04B+10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $22.77B+2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $22.26B+4% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $21.41B+4% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $20.50B+5% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $19.53B+27% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $15.33B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $12.31B−35% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $19.02B+17% | SEC ↗ |
| Q3 2019 | Nov 15, 2019 | $16.28B−15% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $19.11B−13% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $22.03B+8% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $20.48B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $24.25B−3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $25.06B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $23.92B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $23.17B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $22.41B+26% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $17.82B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $17.94B+25% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $14.30B+1% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $14.22B−3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $14.70B+13% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $13.04B | SEC ↗ |